HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Natural Products Sector Will Try Again With $310Bn More Available For Small Business PPP Loans

Executive Summary

NPA found 95% percent of natural food, supplement and cosmetic marketers that applied for a small business loan under CARES Act funding were denied. But industry is hopeful $310bn more made available will lead to more successful applications.

You may also be interested in...

FDA Left Out Of $80M For Stopping Consumer Product Fraud In Latest US COVID-19 Relief Act

American Rescue Plan Act appropriated $50m to Consumer Product Safety Commission and $30.4m to Federal Trade Commission for COVID-19-related enforcement. Neither agency received funding for pandemic-related enforcement in previous relief packages.

NPA In Coalition Pushing For Pandemic Tax Credit In Next US Economic Stimulus Package

NPA part of broad coalition of industry groups asking Congress to provide a tax credit in the next stimulus package to help businesses absorb cost related to COVID-19 safety precautions. NPA notes in a 6 August release that those costs will amount to about $13,595 annually for natural products marketers.

PPP Loans Landed By Nearly 25% Of Natural Product Firms That Tried Again – NPA

Natural products companies fared better in the second round of CARES Act federal PPP funding as a Natural Products Association survey showed 25% that re-applied were successful. It also found 70% of businesses surveyed applied for assistance in the second tranche, which has $120bn still available.

Related Content


Latest News



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts